Startups
AERSKA
Aerska develops RNA interference medicines designed to reach the brain and treat, delay or prevent neurodegenerative diseases.
Team
 Alex BrunickiBoard Member |
Alex ColvilleBoard Member |
Amélie Bowden-FeytoutLab Manager |
Andrew CreganSenior Director, Finance and Administration |
Andy BestPrincipal Scientist, siRNA Lead Development |
Arno de WildeBoard Member |
Dave HardwickeDirector, Head of Business Development, Co-founder |
David CoughlanVP, Head of Early Development |
Duygu YilmazSenior Director, RNA Therapeutics Discovery and Translational Science |
Eugene KimIntellectual Property |
Helen CrehanPrincipal Scientist, Translational Pharmacology |
Hyoungseok JuDirector, Discovery Project |
Ian HugginsSenior Director, Delivery Sciences |
Ines MateusSenior Scientist I |
Itziar CanamasasBoard Member |
Jack O’MearaChief Executive Officer, Co-founder |
Jayesh MajithiyaDirector, Translational Medicine |
Jemimah Keren BungabongOperations Associate |
Jessica McDonaldSenior Director, Program Management & Scientific Operations |
Lalanti VenkatSenior Manager, Business Development and Strategy |
Lisa Taylor AshBoard Member |
Marta DragoshiSenior Manager, Office of the CEO |
Michael PerkintonVP, Head of Research |
Nienke VrienzenDirector, CMC Strategy |
Ollie KingSenior Scientist I |
 Philip ScheltensBoard Observer |
Robyn McAdamPrincipal Scientist |
Sam HandelmanPrincipal Scientist, Clinical Informatics & Data Science |
Saskia ReibePrincipal Scientist, Computational siRNA Lead Development |
Stuart MilsteinChief Platform Officer, Co-founder |
Uli StilzBoard Member |